Long Trip for Psychedelic Drugs

Psychedelic drugs are inching their way slowly but surely toward prescription status in the United States, thanks to a group of persistent scientists who believe drugs like ecstasy and psilocybin can help people with terminal cancer, obsessive-compulsive disorder and post-traumatic stress disorder, to name just a few.
The Heffter Research Institute, the Multidisciplinary Association for Psychedelic Studies and others have managed to persuade the Food and Drug Administration to approve a handful of clinical trials using psychedelics. The movement seems to be gaining ground in recent years. Since 2001, the FDA and the Drug Enforcement Administration have given the go-ahead to three clinical trials testing psychedelics on symptomatic patients, and several more are on deck.
Wired News: Long Trip for Psychedelic Drugs